Alternatives to PAIN Act

1. 01

   How would removing cost-sharing for non-opioid pain medications affect Medicare's overall drug spending and premiums for all beneficiaries?

2. 02

   What evidence suggests that reducing financial barriers to non-opioid alternatives will actually decrease opioid prescriptions and improve patient outcomes?

3. 03

   Which non-opioid medications would qualify for this coverage change, and how would prior authorization elimination impact prescribers' ability to manage appropriate use?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.